New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels
about
Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.Seizures and epilepsy: an overview for neuroscientistsAdenosine dysfunction and adenosine kinase in epileptogenesis.Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats.Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.The effects of preoperative oral pregabalin and perioperative intravenous lidocaine infusion on postoperative morphine requirement in patients undergoing laparatomy.The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential.Emerging drugs for partial-onset epilepsy: a review of brivaracetamIntrinsic severity as a determinant of antiepileptic drug refractoriness.Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy.Amyloid beta a4 precursor protein-binding family B member 1 (FE65) interactomics revealed synaptic vesicle glycoprotein 2A (SV2A) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) as new binding proteins in the human brain.Emerging drugs for partial onset seizures.HCN and KV7 (M-) channels as targets for epilepsy treatment.The dilemma of treatments for epileptic patients with depression.Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological InterventionsCritical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties.Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians.Early Gabapentin Treatment during the Latency Period Increases Convulsive Threshold, Reduces Microglial Activation and Macrophage Infiltration in the Lithium-Pilocarpine Model of Epilepsy.Design, Synthesis, and Docking Study of Pyrimidine-Triazine Hybrids for GABA Estimation in Animal Epilepsy Models.Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.Activation of KCNQ2/3 potassium channels by novel pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives.Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.Synthesis of chiral lactams via asymmetric hydrogenation of α,β-unsaturated nitriles.
P2860
Q27693823-DC4D346E-FE25-499B-8CFE-9FF6F26B0307Q33165796-4FFD5E47-DA3A-419A-9B6C-1A5DA07E482DQ34073789-13F94D74-9CC2-4B61-BAD8-B6D812405FF7Q34114419-C6F9C719-D068-4DA5-80EE-4D76EEBC22EBQ34458158-964A6ECB-DAB1-4AB5-9FBA-86B40D077519Q35939545-2ACE4E46-7B24-48AE-8B60-1795311112F0Q36675813-18E9542A-7CA2-40FA-A38A-F2248BD224D8Q36891212-9CA5C3EC-F46B-4D58-BAB7-D2C9DBB081C4Q36934796-0AD71E0F-3B77-4E58-ADAC-2E1E459CD25DQ37337679-830539A5-FE3A-480E-BC9C-405550380A5AQ37563893-A6BC7FD0-C831-43E8-865C-56F157B73CE9Q37754477-CFFDC6C5-C7C8-44BF-A1CF-4855D94DD630Q37996815-7D08BCDC-D1DA-4E19-AB1A-B454262A0573Q38255835-4C78FE24-E4F0-4B33-BDEE-EB66291A54D9Q38544300-FEA827EF-FBEA-40D8-AA38-0DC91C529A13Q38818082-ADA9B3CA-6BA1-4980-B0F9-6EDCFD0ABF2CQ42385228-B6606CD0-3784-4A61-A01E-E8D9E0807518Q47162131-908F4BE5-31EC-457B-AC07-49AF0E882172Q48323225-093B6E4D-7A57-4BE6-A608-E31A19AE44F5Q48383809-DBED256F-9C0D-4F6B-AE81-B662EE2B6C3AQ51767898-4EBB7731-3DEE-4C96-86AE-A007C2C390B9Q52887626-5F2BD4EB-9E8B-4D29-B31D-CCD7F68C862AQ53154348-F12D1FAF-E1FD-4604-AEBD-5A074929A971
P2860
New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@ast
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@en
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@nl
type
label
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@ast
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@en
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@nl
prefLabel
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@ast
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@en
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@nl
P2860
P3181
P1476
New molecular targets for anti ...... (v)7/KCNQ/M potassium channels
@en
P2093
Carl W Bazil
Michael A Rogawski
P2860
P2888
P304
P3181
P356
10.1007/S11910-008-0053-7
P407
P577
2008-07-01T00:00:00Z
P6179
1018391590